Icatibant Acetate
Icatibant acetate is a selective antagonist of bradykinin B2 receptors. Icatibant is a medication approved for the treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.
| Supplier | BOC Sciences |
|---|---|
| Product # | BAT-010084 |
| Pricing | Inquire |
| Cas | 138614-30-9 |
| Molecular Weight | 1304.52 (free base) |
| Molecular Formula | C59H89N19O13S.xC2H4O2 |
| Canonical SMILES | CC(=O)O.C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O |